Main menu


An Egyptian company produces 71.8 million packages of Corona treatment protocol drugs

The Egyptian International Pharmaceutical Industries-Epico said, in a statement to the Egyptian Stock Exchange, today, Wednesday, that it has produced (Epiflovir-Favipiravir 200), known internationally as Avigan, (Remist), known internationally as remdesivir, used in the treatment protocols drugs for Corona, about 71.804 million packages, either. For the local market and export abroad.


Remast product (Reddemsfer) was exported to Iraq and the Kurdistan region, in addition to other shipments being prepared for export to Uganda. EIPICO's exports of medicines reached 177.8 million pounds in the first quarter of this year, achieving a growth of 33% compared to the same period of the previous year.


The Egyptian International Pharmaceutical Industries-EIPICO had signed a partnership contract in the field of drug manufacturing with the Sudanese Kampal Company, to establish a pharmaceutical factory in Soba area for a joint manufacture of EPICO medicines with a project capital of $ 30 million equally between EIPICO and Kampal, and all studies were completed and started Implementation and construction, and it is planned to complete the construction of the factory within two years to reach the manufacture of medicine at a rate of more than 70%, and the factory will contribute to meeting Sudan's needs of many medicines from various pharmaceutical groups of different pharmaceutical forms, and exporting them to neighboring African countries.